Kenvue’s Neutrogena Moving to NJ

On Apr 12, 2024

Neutrogena, the skin care brand that is part of New Jersey-based Kenvue, announced it is closing its Los Angeles, California office and moving to the Garden State.

The company will move to Skillman, the current headquarters location of Kenvue, and will eventually locate to a corporate campus in Summit which will become Kenvue’s new headquarters.

Kenvue is the multibillion-dollar spinoff of Johnson & Johnson’s consumer health business. Its product portfolio also includes Tylenol, Listerine, and Band-Aid brands.

According to BeautyPacking.com, out of 84 employees who have been laid off in Los Angeles, 74 have been offered employment at other company locations. The company filed a notice with the California Employment Development Office two months ago, outlining the layoff of 84 employees.

In the first quarter of 2024, Kenvue reported an 8% drop in organic sales within its skin health and beauty segment. According to financial filings, Neutrogena and other skin and beauty products account for roughly 20% of Kenvue’s revenue.

Kenvue, the world’s largest pure-play consumer health company by revenue, had net sales of $15.4 billion in 2023. Its spinoff last year from Johnson & Johnson marked the largest restructuring in the latter company’s 135-year history. Kenvue plans to move into its new 290,000-square-foot space in Summit sometime in 2026.

To access more business news, visit NJB News Now.

Related Articles: